China's medical products administrator granted Suzhou Basecare Medical (HKG:2170) medical device approval for its reproductive health gene sequencer, according to a Monday filing with the Hong Kong exchange.
The DA5000 gene sequencer is indicated for use in screening for pre-pregnancy, prenatal, pre-implantation and neonatal genetic disease, according to the filing.
Price (HKD): $2.14, Change: $+0.40, Percent Change: +22.99%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments